6,678 trials
Fractures, Open · Wounds and Injuries--Infections · Anti-Bacterial Agents
Primary: Incidence of Surgical Site Infection During the Post-operative Follow-up Period — 0; 0; 0 participants
Recurrent Urinary Tract Infection · Urinary Tract Infections · Cystitis Recurrent
Primary: Change in Vaginal Microbiota — 2.75 change in percent relative abundance
Relapse Remitting Multiple Sclerosis
Primary: Percentage of Participants Achieving NEDA-3 (No Evidence of Disease Activity-3) — 81.1 percentage of participants
Post Cesarean Pain
Primary: Comparing the Morphine Milligram Equivalents (MME) Use in the First 24 Hours. Postoperatively After Cesarean Section — 7.5; 7.5 Morphine milligram equivalents
Wound Infection · Peripheral Arterial Disease · Aneurysm
Primary: Groin Wound Complication — 6; 19; 1 Participants
Rotator Cuff Tears · Hemorrhage, Surgical · Shoulder Injuries
Primary: Visual Clarity on Endoscope Screen During Shoulder Arthroscopy (Intraoperative) — 7.79; 7.24 units on a scale
Genital Psoriasis · Scalp Psoriasis
Primary: Study-G: Percentage of Participants With Achievement of Static Physician Global Assessment of Genitalia (sPGA-G) of 0 or 1 at Week 16 — 13.0; 69.1 percentage of…
Skin and Subcutaneous Tissue Bacterial Infections · Staphylococcus Aureus · MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Primary: Number of Households With at Least One Skin and Soft Tissue Infection — 21; 21; 22 Households
Premature Birth
Primary: Preterm Birth <37 Weeks — 29; 36 Participants
Traumatic Brain Injury
Primary: Neuropsychiatric Inventory-Irritability Domain - Observer-rated Proportion Improved ≥ 3 Points Baseline to Day-91 — 30; 31 Participants
Coronary Syndrome
Primary: Bleeding Time Difference — 0; 75; -15 s
Common Cold · Cough
Primary: Adjusted Mean Change From Baseline in Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) Total Score — -9.56; -9.11; -26.49; -22.97 score on a scale
Adhesive Capsulitis
Primary: Change in Pain as Assessed by the Shoulder Pain and Disability Index (SPADI) — -37.8; -9.5 score on a scale
Immunization · Efficacy · Human Papilloma Virus
Primary: Short-term Human Papillomavirus (HPV) Type-specific Antibody Response for Type HPV-6 — 99.25; 100.00; 100.00; 100.00 % of participants with seroconversion
Chronic Diarrhea of Unknown Origin
Primary: Number of Participants With a 50 Percent Decrease in Mean Stool Count — 17 Participants